Ucommune International Ltd (UK)
NASDAQ: UK · Real-Time Price · USD
2.170
+0.140 (6.89%)
Sep 1, 2026, 11:00 AM EDT - Market open
Ucommune International Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | 26.12 | 77.21 | 152.03 | 577.81 | 1,058 |
| 26.12 | 77.21 | 152.03 | 577.81 | 1,058 | |
Revenue Growth (YoY | -66.17% | -49.21% | -73.69% | -45.36% | 20.56% |
Property Expenses | 26.87 | 79.01 | 160.89 | 656.65 | 709.83 |
Selling, General & Administrative | 37.38 | 48.51 | 85.76 | 129.31 | 862.32 |
Total Operating Expenses | 64.25 | 127.53 | 246.65 | 785.96 | 1,572 |
Operating Income | -38.13 | -50.31 | -94.62 | -208.15 | -514.64 |
Interest Expense | - | -2.25 | - | -16.84 | -3.26 |
Interest & Investment Income | 0.19 | - | 0.91 | - | - |
Income (Loss) on Equity Investments | - | -0.48 | 0.8 | - | -0.03 |
Other Non-Operating Income | 1.19 | 7.93 | 25.9 | 36.31 | -5.07 |
EBT Excluding Unusual Items | -36.75 | -45.12 | -67.02 | -188.69 | -523 |
Impairment of Goodwill | - | - | - | -16.99 | -1,505 |
Gain (Loss) on Sale of Investments | - | -17.98 | -19.23 | - | -1.37 |
Gain (Loss) on Sale of Assets | 3.22 | -0.61 | 112.79 | 22.95 | -14.98 |
Asset Writedown | -2.95 | -0.97 | -29.11 | -111.31 | -114.49 |
Pretax Income | -36.48 | -64.67 | -2.57 | -294.03 | -2,158 |
Income Tax Expense | 0.09 | 6.37 | 8.28 | 1.02 | 4.48 |
Earnings From Continuing Operations | -36.57 | -71.04 | -10.85 | -295.05 | -2,163 |
Earnings From Discontinued Operations | -1.37 | -3.45 | 1.95 | -15.91 | - |
Net Income to Company | -37.94 | -74.49 | -8.9 | -310.96 | -2,163 |
Minority Interest in Earnings | 0.1 | 4.96 | 3.77 | 19.28 | 166.42 |
Net Income | -37.84 | -69.53 | -5.13 | -291.67 | -1,996 |
Net Income to Common | -37.84 | -69.53 | -5.13 | -291.67 | -1,996 |
Net Income Growth | - | - | - | - | - |
Basic Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Shares Change | 130.18% | 116.72% | 47.25% | 2.19% | 32.42% |
EPS (Basic) | -140.26 | -593.21 | -94.89 | -7941.25 | -55545.41 |
EPS (Diluted) | -140.26 | -593.21 | -94.89 | -7941.25 | -55545.41 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Margin | -145.96% | -65.16% | -62.24% | -36.02% | -48.67% |
Profit Margin | -144.88% | -90.05% | -3.38% | -50.48% | -188.78% |
EBITDA | -34.91 | -40.65 | -76.78 | -161.76 | -432.79 |
EBITDA Margin | -133.64% | -52.64% | -50.51% | -27.99% | -40.92% |
D&A For Ebitda | 3.22 | 9.67 | 17.84 | 46.39 | 81.85 |
EBIT | -38.13 | -50.31 | -94.62 | -208.15 | -514.64 |
EBIT Margin | -145.96% | -65.16% | -62.24% | -36.02% | -48.67% |
Revenue as Reported | 26.12 | 77.21 | 152.03 | 577.81 | 1,058 |